Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells From Human Exfoliated Teeth for Type 2 Diabetes
NCT03658655Phase 1Completed
- Sponsor
- CARsgen Therapeutics
- Start
- Jun 2018
- Primary completion
- Nov 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Stem Cells From Human Exfoliated Teeth in type 2 diabetes mellitus (T2DM), sponsored by CARsgen Therapeutics. Primary endpoint: Total daily insulin at 1 week. Started Jun 2018; status: completed.
02
Drugs
Stem Cells From Human Exfoliated Teeth
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03658655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658655.